D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
CALL
Assured Guaranty
AGO
$3.78B
| $3.04M | ﹤0.01% |
117,900
| – | – |
|
1777
Sarepta Therapeutics
SRPT
$1.68B
| $3.04M | ﹤0.01% |
31,060
+27,228
| +711% | +$3.11M |
|
1778
Takeda Pharmaceutical
TAK
$55.7B
| $3.04M | ﹤0.01% |
200,080
-340,536
| -63% | -$6.17M |
|
1779
PUT
Bread Financial
BFH
$4.29B
| $3.02M | ﹤0.01% |
112,645
+9,398
| +9% | +$640K |
|
1780
CALL
Capital One
COF
$127B
| $3.02M | ﹤0.01% |
60,000
-16,500
| -22% | -$1.45M |
|
|
CXO
1781
CALL
DELISTED
CONCHO RESOURCES INC.
CXO
| $3.02M | ﹤0.01% |
70,600
-5,000
| -7% | -$348K |
|
1782
Emcor
EME
$33B
| $3.02M | ﹤0.01% |
49,281
+43,483
| +750% | +$3.35M |
|
1783
Molson Coors Class B
TAP
$7.71B
| $3.01M | ﹤0.01% |
77,209
-245,090
| -76% | -$12.4M |
|
|
HUD
1784
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $3M | ﹤0.01% |
598,399
+260,694
| +77% | +$2.58M |
|
|
DCH
1785
Dauch Corp
DCH
$1.32B
| $3M | ﹤0.01% |
829,732
+165,582
| +25% | +$1.23M |
|
1786
PUT
Ralph Lauren
RL
$22.6B
| $2.99M | ﹤0.01% |
44,800
-29,100
| -39% | -$3.06M |
|
1787
Energizer
ENR
$1.44B
| $2.99M | ﹤0.01% |
98,945
+82,071
| +486% | +$3.72M |
|
1788
Papa John's
PZZA
$997M
| $2.99M | ﹤0.01% |
56,087
-18,215
| -25% | -$1.1M |
|
1789
OR Royalties Inc
OR
$5.54B
| $2.99M | ﹤0.01% |
401,434
+234,474
| +140% | +$2.08M |
|
|
ONDK
1790
DELISTED
On Deck Capital, Inc.
ONDK
| $2.99M | ﹤0.01% |
1,938,858
-272,755
| -12% | -$889K |
|
1791
Regenxbio
RGNX
$622M
| $2.98M | ﹤0.01% |
92,163
+68,402
| +288% | +$2.85M |
|
1792
Phibro Animal Health
PAHC
$1.43B
| $2.98M | ﹤0.01% |
123,249
+44,621
| +57% | +$1.09M |
|
1793
Illinois Tool Works
ITW
$81.9B
| $2.97M | ﹤0.01% |
+20,880
| New | +$3.55M |
|
|
ZUO
1794
DELISTED
Zuora, Inc.
ZUO
| $2.96M | ﹤0.01% |
368,172
+55,545
| +18% | +$731K |
|
1795
Insperity
NSP
$1.92B
| $2.96M | ﹤0.01% |
79,381
-139,527
| -64% | -$9.9M |
|
1796
FormFactor
FORM
$7.7B
| $2.96M | ﹤0.01% |
147,158
+136,116
| +1,233% | +$3.25M |
|
1797
CALL
Synaptics
SYNA
$4.55B
| $2.96M | ﹤0.01% |
51,100
+22,800
| +81% | +$1.55M |
|
|
DRNA
1798
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.96M | ﹤0.01% |
160,849
+41,579
| +35% | +$808K |
|
1799
PUT
Coherent
COHR
$53.1B
| $2.95M | ﹤0.01% |
103,600
| – | – |
|
|
BERY
1800
PUT
DELISTED
Berry Global Group, Inc.
BERY
| $2.95M | ﹤0.01% |
95,396
+52,816
| +124% | +$1.94M |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.